AstraZeneca’s vexing vaccine
Aug 06, 2021
2 minutes
AstraZeneca is “reviewing the future of the Covid-19 vaccines business”, says Farah Ghouri in City AM – and could decide to exit vaccines altogether. Its jab helped boost overall sales by almost a quarter to $15.5bn in the first half of 2021. But AstraZeneca has suffered
You’re reading a preview, subscribe to read more.
Start your free 30 days